|View printer-friendly version|
|The Accuray Radixact™ System Receives Shonin Approval|
The Radixact System was designed to be an easy-to-operate, highly reliable, advanced radiation therapy device. The System features a more powerful linear accelerator, low-dose fan beam MVCT imaging and unique helical treatment mode, so that clinicians can deliver highly accurate, individualized dose distributions to any tumor. The fully-integrated, simplified adaptive treatment planning solution enables clinicians to routinely adjust treatment plans during the course of treatment to account for changes in tumor size, shape and location – thereby increasing treatment precision.
"The approval of the Radixact System represents a key milestone in our strategic growth plans for the Japanese market," said
For more information about the Radixact platform, visit: http://www.accuray.com/radixact.
Safe Harbor Statement
Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-accuray-radixact-system-receives-shonin-approval-300403925.html